These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 338900)

  • 21. Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.
    Ikeda K; Yoshisue K; Matsushima E; Nagayama S; Kobayashi K; Tyson CA; Chiba K; Kawaguchi Y
    Clin Cancer Res; 2000 Nov; 6(11):4409-15. PubMed ID: 11106261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative studies on the metabolism of 2-(tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
    Toide H; Akiyoshi H; Minato Y; Okuda H; Fujii S
    Gan; 1977 Oct; 68(5):553-60. PubMed ID: 22472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of 5-fluorouracil analogs on humoral and cell-mediated responses in mice: augmentation of delayed hypersensitivity response against picryl chloride by 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD-1), a new anti-tumor drug.
    Yamada Y; Miyauchi S; Unemi N
    J Clin Lab Immunol; 1980 Nov; 4(3):153-7. PubMed ID: 6451710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-pressure liquid chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur.
    Marunaka T; Umeno Y; Yoshida K; Nagamachi M; Minami Y; Fujii S
    J Pharm Sci; 1980 Nov; 69(11):1296-300. PubMed ID: 6778988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of tRNA 5-methyluridine methyltransferase and pseudouridine synthetase activities in 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur)-treated Escherichia coli.
    Frendewey DA; Kladianos DM; Moore VG; Kaiser II
    Biochim Biophys Acta; 1982 Apr; 697(1):31-40. PubMed ID: 6805514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzymatic formation of 5-fluorouracil from 1-(tetrahydro-2-furanyl)- 5-fluorouracil (tegafur) in human tumor tissues.
    Kono A; Hara Y; Matsushima Y
    Chem Pharm Bull (Tokyo); 1981 May; 29(5):1486-8. PubMed ID: 6794918
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative antitumor activity of 5-fluorouracil and its prodrugs in combination with hyperthermia in vitro.
    Shiiki S; Fuchimoto S; Iwagaki H; Akazai Y; Matsubara N; Watanabe T; Orita K
    Acta Med Okayama; 1991 Oct; 45(5):339-45. PubMed ID: 1836706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synthesis of 3-(tetrahydro-2-furanyl)-5-fluorouracil (author's transl)].
    Yasumoto M; Yamashita J; Hashimoto S
    Yakugaku Zasshi; 1978 Nov; 98(11):1551-3. PubMed ID: 368311
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo effects of 5-fluorouracil and ftorafur[1-(tetrahydrofuran-2-yl)-5-fluorouracil] on murine mammary tumors and small intestine.
    Pallavicini MG; Cohen AM; Dethlefsen LA; Gray JW
    Cell Tissue Kinet; 1979 Mar; 12(2):177-89. PubMed ID: 371813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of L-cysteine on plasma concentration and urinary excretion of 1-(tetrahydro-2-furanyl)-5-fluorouracil metabolites.
    Kawabata N; Yano K; Ohno H; Nakashima T
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):1068-71. PubMed ID: 1893491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Fluorouracil concentrations in human plasma following R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) administration.
    Au JL; Sadée W
    Cancer Res; 1979 Oct; 39(10):4289-90. PubMed ID: 383283
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liver.
    Ozawa S; Hamada M; Murayama N; Nakajima Y; Kaniwa N; Matsumoto Y; Fukuoka M; Sawada J; Ohno Y
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):454-8. PubMed ID: 12451471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship in Ftorafur (Tegafur) and related 5-FU prodrugs.
    Zhuk R
    Adv Exp Med Biol; 1998; 431():677-80. PubMed ID: 9598151
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma.
    Kawata S; Noda S; Imai Y; Tamura S; Saitoh R; Miyoshi S; Minami Y; Tarui S
    Gastroenterol Jpn; 1987 Feb; 22(1):55-62. PubMed ID: 3032726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of immunopotentiators on the activation of 5-FU derivatives].
    Nakazato H; Kito T; Yasue M; Yamamura Y; Kobari T; Hirakawa T; Hatta M
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):867-74. PubMed ID: 3920971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Species variation in the enantioselective metabolism of tegafur to 5-fluorouracil among rats, dogs and monkeys.
    Yamamiya I; Yoshisue K; Ishii Y; Yamada H; Yoshida K
    J Pharm Pharmacol; 2014 Dec; 66(12):1686-97. PubMed ID: 25117829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of a new antimetabolic agent, 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD-1).
    Taguchi T
    Recent Results Cancer Res; 1980; 70():133-45. PubMed ID: 6766562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver.
    Komatsu T; Yamazaki H; Shimada N; Nagayama S; Kawaguchi Y; Nakajima M; Yokoi T
    Clin Cancer Res; 2001 Mar; 7(3):675-81. PubMed ID: 11297264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug interaction of antitumor drugs. III. Antitumor activity of tegafur in lipopolysaccharide-treated mice.
    Sasaki K; Furusawa S; Takayanagi G
    Jpn J Pharmacol; 1982 Dec; 32(6):1135-42. PubMed ID: 6819375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.